Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Arterial dissection-lentiginosis is a rare association syndrome, reported in several members of two families to date, and characterized by arterial dissection, occurring at an early age and presenting with a range of manifestations depending on the vascular territory involved (ex. headache, dysphasia, hemiparesis), in association with cystic medial necrosis and multiple lentigines (brown and black in color and mainly affecting the skin of the trunk and extremities).
Features include: Multiple lentigines, Cystic medial necrosis, and Arterial dissection.
Biomarker and diagnostic research for arterial dissection-lentiginosis syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for arterial dissection-lentiginosis syndrome.
201 publications have been identified in PubMed for arterial dissection-lentiginosis syndrome. Kisho has analyzed 97 by research type. Research spans Review / Meta-Analysis (49%), Case Report / Case Series (22%), and Epidemiology / Natural History (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 48 | 49% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
21 |
22% |
Disease patterns and progression | 11 | 11% |
Laboratory research | 8 | 8% |
Testing and diagnosis research | 4 | 4% |
Clinical study results | 3 | 3% |
Other research | 2 | 2% |
Jutant EM (2026). [PMID: 41813013](https://pubmed.ncbi.nlm.nih.gov/41813013/). *Eur Respir Rev*. [Review / Meta-Analysis]
Duvvuri M (2026). [PMID: 41896014](https://pubmed.ncbi.nlm.nih.gov/41896014/). *Handb Clin Neurol*. [Review / Meta-Analysis]
Gonzalez-Urquijo M (2026). [PMID: 41121996](https://pubmed.ncbi.nlm.nih.gov/41121996/). *Am Surg*. [Review / Meta-Analysis]
Stephan D (2026). [PMID: 41826108](https://pubmed.ncbi.nlm.nih.gov/41826108/). *Vasc Dis (Paris)*. [Review / Meta-Analysis]
Sanhueza-Olivares F (2026). [PMID: 39930974](https://pubmed.ncbi.nlm.nih.gov/39930974/). *J Physiol*. [Basic Science / Preclinical]
Mokhlesi B (2026). [PMID: 41309270](https://pubmed.ncbi.nlm.nih.gov/41309270/). *Eur Respir J*. [Review / Meta-Analysis]
Shimizu C (2026). [PMID: 41150874](https://pubmed.ncbi.nlm.nih.gov/41150874/). *Annu Rev Pathol*. [Review / Meta-Analysis]
Polimeni A (2026). [PMID: 41432717](https://pubmed.ncbi.nlm.nih.gov/41432717/). *Am J Physiol Heart Circ Physiol*. [Review / Meta-Analysis]
Riascos-Bernal DF (2026). [PMID: 40935270](https://pubmed.ncbi.nlm.nih.gov/40935270/). *Trends Cardiovasc Med*. [Review / Meta-Analysis]
Janion A (2026). [PMID: 42015722](https://pubmed.ncbi.nlm.nih.gov/42015722/). *Pol Przegl Chir*. [Review / Meta-Analysis]